The clinical-epidemiological cancer registry of Rhineland-Palatinate collects comprehensive inpatient and outpatient data on the occurrence, treatment and course of tumor diseases.

Cancer is still the second most common cause of death in Germany after cardiovascular diseases. The aim of cancer registration is to use the data collected to improve oncological care, in particular the treatment of tumor patients.

Mission and Goals

  • Comprehensive data with a wide range of analysis options are made available for science and research.

  • Through the comprehensive evaluation of all treatment data in clinical cancer registries, successful treatment methods become visible more quickly.

  • Prompt evaluation and feedback to oncologists reflects information relevant to care.

  • In the long term, clinical cancer registries contribute to the establishment of uniform quality assurance in oncological care throughout Germany.

Our mission statement

Patients are at the center of everything we do.

The cancer registry assumes responsibility for

  • the security of the data as a reliable partner

  • the quality of the data as a renowned partner

  • the use of the data as a strategic partner

of science, research and all oncologists.

  1. The Cancer Registry makes an important contribution to improving the treatment of patients with cancer.

  2. The Cancer Registry supports and initiates internal and external research and care projects with quality-assured data.

  3. The Cancer Registry is a legally legitimized, independent body for quality assurance in oncological care.

Privacy Protection

The protection of data is one of the most important corner stones for the Cancer Registry Rhineland-Palatinate. How is your personal information protected?

  • The data processing in the Cancer Registry Rhineland-Palatinate is strictly confidential and subject to medical supervision.
  • The technical and organizational measures to protect the data conform to the latest safety standards.
  • The work of the Cancer Registry Rhineland-Palatinate is accompanied by the State Commissioner for Data Protection and Freedom of Information of the Rhineland-Palatinate.
  • Any use of the data for quality assurance and for research purposes is done according to strict, legally prescribed requirements and without a name relation (encrypted/ pseudonym)
  • If your name is required for specific research projects, you will be notified in advance for your consent. This information will only be used if you have expressly consented to its usage.

The federal law regulating early cancer detection and registration has been enacted in April 2013. In §65c SGB V, the law regulates the installation, mission and financing of the clinical cancer registration in Germany. At the end of 2015, the state government of Rhineland-Palatinate has decided that the existing epidemiological cancer registry in the state will take over the tasks of clinical cancer registration as well and in accordance with the legal situation. Thus the state’s cancer registry law has come to effect on January 1, 2016.